News

CABIO Deepens Commitment to Global Markets, Aiming to Serve International Client

2024-11-21

CABIO, a high-tech enterprise underpinned by biotechnology and listed on the Science and Technology Innovation Board (stock code: 688089), unveiled its innovative product, NeoHMOs®, at the Food Ingredients Europe event held in Frankfurt, Germany.

More

NeoHMOs®: Premium Nutrition Extends Maternal Love and Protection

2024-12-20

Premium Nutrition Extends Maternal Love and Protection.

More

CABIO Biotech and Nourish Ingredients Announce Strategic Partnership

2024-11-12

Actively Expanding CABIO's Product Portfolio and Deeply Engaging in the Global Innovative Food Ingredient Industry.

More

Semiannual Report 2023 | Firm Confidence in Sustainable Development: CABIO Conti

2023-08-31

We published our semiannual report 2023 on August 26, 2023. In the 1st half of the year, we realized RMB 199 million in revenue

More

"Biotechnology Nourishes Life", CABIO explores the development of Synthetic Biol

2023-06-14

On June 9, 2023, the Synthetic Biology Technology Development Summit was held in Wuhan Optics Valley. The Summit was hosted by China Biotech Fermentation Industry Association and jointly undertaken by CABIO Biotech (Wuhan) Co., Ltd., Hubei Society for Mic

More

Cabio’s partnership enables consumer product innovation, diversification.

2023-04-27

On April 26, Jinhaikang obtained a baby liquid FSDU manufacturing license — also the first in Guangdong. The event marked the enablement by Cabio, a biotechnological giant, of its advantage in nutrition and healthcare in cooperation with Jinhaikang

More

CABIO showcases the new products and Ready-to-Market solutions at Vitafoods Euro

2023-05-09

CABIO showcases three new ingredients — HMOs, Salecan® β-glucan and elastin — as well as its already well-known ARA, algal oil DHA, β-Carotene and sialic acid (SA) during the exhibition.

More

CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ing

2022-12-07

CABIO, a provider of high-quality functional ingredients and innovative solutions for customers worldwide, has been participating in the event for many years, with the aim of sharing its research results and innovative solutions with consumers and industr

More

Official Ground-breaking Ceremony of Wuhan Synthetic Biology Innovation Center

2022-10-21

Official Ground-breaking Ceremony of Wuhan Synthetic Biology Innovation Center & CABIO R&D Center Investment Project.

More

CABIO participates in the Food Ingredients Aisa in Indonesia (FIA)

2022-09-15

On September 7-9, 2022, The CABIO International team participated in the Food Ingredients Asia in Indonesia.

More

CABIO released its 2021 Annual Report.

2022-02-14

In 2021, CABIO reaped RMB351,109,348.43, up by 8.55% from the preceding year. The net profit attributable to equity holders of the Company totaled RMB128,578,881.86, down by 1.54% from the preceding year.

More

CABIO receives USDA Organic certification for its Docosahexaenoic Acid Algae Oil

2021-11-29

CABIO has obtained USDA Organic certification for its Docosahexaenoic Acid Oil, Aquatic plants Seaweed and DHA Algae Oil.

More